Ulthera technology recognized for exellence

Ultherapy(R) Named “Best In-Office Treatment” in NewBeauty’s Annual Beauty Choice Awards

MESA, AZ–(Marketwired – Jan 22, 2014) –  Ulthera, Inc. — a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications — announced today that its signature non-invasive lifting treatment, Ultherapy, was named “Best In-Office Treatment” in NewBeauty’s 2013 Beauty Choice Awards.

“We are honored to be recognized by NewBeauty and its readers, and even more privileged to be selected as the favored in-office procedure available in cosmetic medical practices today,” said Matthew Likens, president and CEO of Ulthera. “As the only non-invasive treatment with an aesthetic lifting indication from the FDA, Ultherapy fills an unmet need for those looking to non-surgically treat sagging skin, especially in hard-to-treat areas such as the neck, under the chin and above the brow.”

NewBeauty’s Annual Beauty Choice Awards recognize the best products on the market as determined by thousands of NewBeauty readers as well as the magazine’s editors and renowned beauty experts. This is the first year NewBeauty has included “Best In-Office Treatment” as an Award category. A complete list of Award winners were unveiled in the Winter/Spring 2014 issue of NewBeauty, on newsstands now.

About Ulthera
Ulthera, Inc. is a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive U.S. FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is an FDA-cleared treatment to lift skin above the brow, on the neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company. For more information, visit www.ultherapy.com.

Media Contact:
Lindsey Karberg
Ulthera, Inc.
480.336.1744
Email Contact

Posted in AZBio News and tagged .